Interaction of c-Src with Gap Junction Protein Connexin-43

Ben N. G. Giepmans, Trudi Hengeveld, Friso R. Postma, Wouter H. Moolenaar

Journal of Biological Chemistry · 2001 · 179 citations · 15 references

DOIFull text

Open access

Concepts

Abstract

Cell-cell communication via connexin-43 (Cx43)-based gap junctions is transiently inhibited by certain mitogens, but the underlying regulatory mechanisms are incompletely understood. Our previous studies have implicated the c-Src tyrosine kinase in mediating transient closure of Cx43-based gap junctions in normal fibroblasts. Here we show that activated c-Src (c-SrcK+) phosphorylates the COOH-terminal tail of Cx43, both in vitro and in intact cells. Coimmunoprecipitation experiments reveal that Cx43 associates with c-SrcK+ and, to a lesser extent, with wild-type c-Src, but not with kinase-dead c-Src. Mutation of residue Cx43 Tyr265 (Cx43-Y265F mutant) abolishes both tyrosine phosphorylation of Cx43 and its coprecipitation with c-Src. Expression of c-SrcK+ in Rat-1 cells disrupts gap junctional communication. Strikingly, the communication-defective phenotype is bypassed after coexpression of the Cx43-Y265F mutant or a COOH-terminally truncated version of Cx43 (Cx43Δ263) that lacks residue Tyr265. Our results support a model in which activated c-Src phosphorylates the COOH-terminal tail of Cx43 on residue Tyr265, resulting in a stable interaction between both proteins leading to inhibition of gap junctional communication. Cell-cell communication via connexin-43 (Cx43)-based gap junctions is transiently inhibited by certain mitogens, but the underlying regulatory mechanisms are incompletely understood. Our previous studies have implicated the c-Src tyrosine kinase in mediating transient closure of Cx43-based gap junctions in normal fibroblasts. Here we show that activated c-Src (c-SrcK+) phosphorylates the COOH-terminal tail of Cx43, both in vitro and in intact cells. Coimmunoprecipitation experiments reveal that Cx43 associates with c-SrcK+ and, to a lesser extent, with wild-type c-Src, but not with kinase-dead c-Src. Mutation of residue Cx43 Tyr265 (Cx43-Y265F mutant) abolishes both tyrosine phosphorylation of Cx43 and its coprecipitation with c-Src. Expression of c-SrcK+ in Rat-1 cells disrupts gap junctional communication. Strikingly, the communication-defective phenotype is bypassed after coexpression of the Cx43-Y265F mutant or a COOH-terminally truncated version of Cx43 (Cx43Δ263) that lacks residue Tyr265. Our results support a model in which activated c-Src phosphorylates the COOH-terminal tail of Cx43 on residue Tyr265, resulting in a stable interaction between both proteins leading to inhibition of gap junctional communication. connexin-43 ethidium bromide green fluorescent protein gap junctional communication glutathione S-transferase lysophosphatidic acid Lucifer Yellow polyacrylamide gel electrophoresis wild-type Gap junctions mediate communication between adjacent cells in almost all tissues. Gap junctions are composed of arrays of channel-forming integral membrane proteins, termed connexins (for review, see Refs. 1Goodenough D.A. Goliger J.A. Paul D.L. Annu. Rev. Biochem. 1996; 65: 475-502Crossref PubMed Scopus (1075) Google Scholar and 2Kumar N.M. Gilula N.B. Cell. 1996; 84: 381-388Abstract Full Text Full Text PDF PubMed Scopus (1635) Google Scholar). The connexin proteins contain four transmembrane domains with the amino- and COOH-terminal regions located intracellularly. Connexin-43 (Cx43)1 is the most widespread and best studied member of the connexin family, with much attention being focused on its regulation by physiological and pathophysiological stimuli. Cx43-based gap junctional communication (GJC) is transiently inhibited by certain growth factors (1Goodenough D.A. Goliger J.A. Paul D.L. Annu. Rev. Biochem. 1996; 65: 475-502Crossref PubMed Scopus (1075) Google Scholar, 3Lau A.F. Kanemitsu M.Y. Kurata W.E. Danesh S. Boynton A.L. Mol. Biol. Cell. 1992; 3: 865-874Crossref PubMed Scopus (170) Google Scholar, 4Hii C.S. Oh S.Y. Schmidt S.A. Clark K.J. Murray A.W. Biochem. J. 1994; 303: 475-479Crossref PubMed Scopus (76) Google Scholar, 5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar, 6Hossain M.Z. Jagdale A.B. Ao P. Kazlauskas A. Boynton A.L. J. Biol. Chem. 1999; 274: 10489-10496Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar) and permanently reduced or disrupted in most cancer cells and in v-Src-transformed fibroblasts (1Goodenough D.A. Goliger J.A. Paul D.L. Annu. Rev. Biochem. 1996; 65: 475-502Crossref PubMed Scopus (1075) Google Scholar, 7Chang C.C. Trosko J.E. Kung H.J. Bombick D. Matsumura F. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 5360-5364Crossref PubMed Scopus (85) Google Scholar, 8Crow D.S. Beyer E.C. Paul D.L. Kobe S.S. Lau A.F. Mol. Cell. Biol. 1990; 10: 1754-1763Crossref PubMed Scopus (304) Google Scholar, 9Filson A.J. Azarnia R. Beyer E.C. Loewenstein W.R. Brugge J.S. Cell Growth Differ. 1990; 1: 661-668PubMed Google Scholar, 10Hotz-Wagenblatt A. Shalloway D. Crit. Rev. Oncogenesis. 1993; 4: 541-558PubMed Google Scholar, 11Kanemitsu M.Y. Loo L.W. Simon S. Lau A.F. Eckhart W. J. Biol. Chem. 1997; 272: 22824-22831Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar). The COOH-terminal tail of Cx43 contains several serine/threonine and tyrosine phosphorylation sites that are thought to be important for regulating the opening and closure (“gating”) of Cx43-based channels (1Goodenough D.A. Goliger J.A. Paul D.L. Annu. Rev. Biochem. 1996; 65: 475-502Crossref PubMed Scopus (1075) Google Scholar), but little is still known about how phosphorylation of Cx43 may be linked to the regulation of GJC. We have reported that Cx43-based GJC in normal fibroblasts is rapidly inhibited after activation of certain G protein-coupled receptors, such as those for lysophosphatidic acid (LPA), endothelin, and thrombin (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). We found that agonist-induced gap junction closure is independent of classic second messengers, such as calcium and cyclic nucleotides, and does not require the mitogen-activated protein kinase cascade. Instead, gap junction closure was prevented by tyrosine kinase inhibitors, by dominant-negative c-Src, and in c-Src-deficient cells (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). It thus appears that the c-Src tyrosine kinase is required for disruption of Cx43-based GJC by these G protein-coupled receptor agonists. Although agonist-induced tyrosine phosphorylation of Cx43 could not be detected (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar), the possibility remains that active c-Src may directly interact with Cx43 by analogy of what has been reported for oncogenic v-Src, whose effects on Cx43 and Cx43-based GJC have been investigated extensively (1Goodenough D.A. Goliger J.A. Paul D.L. Annu. Rev. Biochem. 1996; 65: 475-502Crossref PubMed Scopus (1075) Google Scholar, 7Chang C.C. Trosko J.E. Kung H.J. Bombick D. Matsumura F. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 5360-5364Crossref PubMed Scopus (85) Google Scholar, 8Crow D.S. Beyer E.C. Paul D.L. Kobe S.S. Lau A.F. Mol. Cell. Biol. 1990; 10: 1754-1763Crossref PubMed Scopus (304) Google Scholar, 9Filson A.J. Azarnia R. Beyer E.C. Loewenstein W.R. Brugge J.S. Cell Growth Differ. 1990; 1: 661-668PubMed Google Scholar, 10Hotz-Wagenblatt A. Shalloway D. Crit. Rev. Oncogenesis. 1993; 4: 541-558PubMed Google Scholar, 11Kanemitsu M.Y. Loo L.W. Simon S. Lau A.F. Eckhart W. J. Biol. Chem. 1997; 272: 22824-22831Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar, 12Swenson K.I. Piwnica-Worms H. McNamee H. Paul D.L. Cell Regul. 1990; 1: 989-1002Crossref PubMed Scopus (226) Google Scholar, 13Zhou L. Kasperek E.M. Nicholson B.J. J. Cell Biol. 1999; 144: 1033-1045Crossref PubMed Scopus (146) Google Scholar). Residue Tyr265 in the COOH-terminal tail of Cx43 has been implicated as a major target for the v-Src kinase, but uncertainty exists as to the relevance of Tyr265 phosphorylation in channel gating (12Swenson K.I. Piwnica-Worms H. McNamee H. Paul D.L. Cell Regul. 1990; 1: 989-1002Crossref PubMed Scopus (226) Google Scholar, 13Zhou L. Kasperek E.M. Nicholson B.J. J. Cell Biol. 1999; 144: 1033-1045Crossref PubMed Scopus (146) Google Scholar). InXenopus oocyte pairs, v-Src-mediated closure of Cx43-based gap junctions was shown to be critically dependent on residue Tyr265, since mutation of Tyr265 in Cx43 prevented gap junction closure (12Swenson K.I. Piwnica-Worms H. McNamee H. Paul D.L. Cell Regul. 1990; 1: 989-1002Crossref PubMed Scopus (226) Google Scholar). In contrast, more recent experiments using the Xenopus system have suggested that v-Src-induced inhibition of Cx43-based GJC occurs via a pathway that is independent of the Tyr265 site but seems to require serine phosphorylation sites for mitogen-activated protein kinase (13Zhou L. Kasperek E.M. Nicholson B.J. J. Cell Biol. 1999; 144: 1033-1045Crossref PubMed Scopus (146) Google Scholar). The reason for the discrepancy between both studies is unclear. While the action of oncogenic v-Src on Cx43 has been examined in considerable detail, it remains unknown whether endogenous wild-type c-Src can act similarly on Cx43. Overexpressed c-Src has long been known to mimic v-Src in inhibiting GJC in 3T3 cells (14Azarnia R. Reddy S. Kmiecik T.E. Shalloway D. Loewenstein W.R. Science. 1988; 239: 398-401Crossref PubMed Scopus (138) Google Scholar). However, where tested, an association between wild-type c-Src and Cx43 in vivo could not be detected (11Kanemitsu M.Y. Loo L.W. Simon S. Lau A.F. Eckhart W. J. Biol. Chem. 1997; 272: 22824-22831Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar). In the present study we have examined the possible interaction between c-Src and Cx43, both in vitro and in transfected cells. We find that residue Tyr265 in the COOH-terminal tail of Cx43 is phosphorylated by active c-Src and, furthermore, that Cx43 and active c-Src can be coprecipitated, whereas kinase-dead c-Src fails to stably interact with Cx43. Tyrosine phosphorylation and coprecipitation of Cx43 are abolished after mutation of residue Cx43 Tyr265. The communication-defective phenotype can be bypassed after introduction of mutant versions of Cx43 that cannot be tyrosine-phosphorylated on Tyr265. We conclude that activated c-Src phosphorylates the C-terminal tail of Cx43 on residue Tyr265, resulting in a stable interaction between both proteins that contributes to the inhibition of GJC by extracellular agonists. Rat-1 cells, COS-7, A431, and HeLa cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Prior to experimentation, cells were serum-starved for 16 h. Chicken c-SrcY527A (SrcK+), c-SrcK295m (SrcK−), and c-Src in pMT2 were kindly provided by S. Courtneidge (Sugen, Inc., Redwood City, CA). Myc epitope-tagged full-length Cx43 and Cx43Δ263 in pCDNA3 (Invitrogen) were constructed as described previously (15Giepmans B.N. Moolenaar W.H. Curr. Biol. 1998; 8: 931-934Abstract Full Text Full Text PDF PubMed Scopus (471) Google Scholar). The Cx43Y265F and Cx43Y267F mutations were introduced by site-directed mutagenesis using 5′ oligonucleotides (5′ TGC GGA TCC CCA AAA TTC GCC TAC TTC AAT GGC T 3′ and 5′ TGC GGA TCC CCA AAA TAC GCC TTC TTC AAT GGC TGC TCC T 3′, respectively) and the 3′ oligonucleotide (5′ GGG GCGGCCGC C AAT CTC CAG GTC ATC AG 3′). Polymerase chain reaction was performed according to standard procedures, using rat Cx43 cDNA as template. Polymerase chain reaction products were isolated from gel andBamHI/NotI ligated into Cx43Δ263Myc, in which aBamHI site was introduced in the nucleotides encoding amino acids 261 and 262 (silent mutation). Mutations were verified by sequencing. To construct GST-Cx43CT, the COOH-terminal tail of Cx43 was isolated from pMD4Cx43CT (15Giepmans B.N. Moolenaar W.H. Curr. Biol. 1998; 8: 931-934Abstract Full Text Full Text PDF PubMed Scopus (471) Google Scholar) with SalI/EcoRI and ligated, in frame with glutathione S-transferase (GST) cDNA, into pGEX-1n (XhoI/EcoRI). GST and GSTCxCT proteins were isolated from DH5α bacteria induced with isopropyl-β-d-thioglactopyranoside according standard procedures. GFP in pMT2 was obtained from G. Zondag (The Netherlands Cancer Institute). Cells were transfected with pCDNA3 plasmid encoding Myc-tagged Cx43 and/or versions of c-Src using standard calcium phosphate precipitation. COS cells were transfected by the standard DEAE-dextran transfection method, using 1 “g of plasmid DNA per 105 cells. Mouse anti-Cx43 and anti-phosphotyrosine (PY20) monoclonal antibodies were from Transduction Laboratories (Lexington, KY). Mouse anti-Myc was applied as culture supernatant from the 9E10 hybridoma (ATCC). Rabbit anti-human c-Src (SRC2) was from Santa Cruz Biotechnology (Santa Cruz, CA), and mouse anti v-Src monoclonal antibody was from Calbiochem. Secondary antibodies (rabbit anti-mouse and swine anti-rabbit) conjugated to horseradish peroxidase were obtained from Dako (Glostrup, Denmark), and antibodies conjungated to Texas Red were from Molecular Probes (Leiden, The Netherlands). Cells were lysed in 1% Nonidet P-40, 0.25% sodium deoxycholate lysis buffer as described previously (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). Lysates were clarified and precipitated with antibody precoupled to protein A-Sepharose Cl-4B (Amersham Pharmacia Biotech, Uppsala, Sweden). Incubation was for 1 h to overnight at 4 °C. Precipitates were washed, and proteins were eluted in Laemmli sample buffer (LSB: 50 mm Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.1% bromphenol blue). Src was expressed in COS-7 cells as described above. Cells were lysed 40 h post-transfection in Triton X-100 buffer (150 mm NaCl, 50 mm Tris-Cl, pH 7.4, 2 mm EGTA, and 0.1% Triton X-100). Src immunoprecipitates were washed in in vitro kinase buffer (IVKB: 1 mm dithiothreitol, 10 mm MgCl2, 50 mm Tris-Cl, pH 7.4). Substrate (10 “g of GST and GST-Cx43CT) and 0.37 Mbq of [γ-32P]ATP (Amersham Pharmacia Biotech) were added in IVKB. Reactions carried out at 30 °C were stopped after 1 h with LSB. Samples were subjected to SDS-PAGE and analyzed by autoradiography and immunoblotting. Samples in LSB were boiled for 5 min, subjected to SDS-PAGE (12.5% gel), and transferred to nitrocellulose, as described previously (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). The blots were blocked and subsequently probed with primary and secondary antibodies. Immunostained proteins were visualized using enhanced chemoluminescence (Amersham Pharmacia Biotech). Scrape-loading of lucifer yellow, microinjections, electrophysiological measurements, and immunofluorescence assays were carried out as described previously (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). Previous studies have shown that Cx43 is tyrosine-phoshorylated by oncogenic v-Src, which correlates with permanent disruption of GJC in v-Src-transformed cells (1Goodenough D.A. Goliger J.A. Paul D.L. Annu. Rev. Biochem. 1996; 65: 475-502Crossref PubMed Scopus (1075) Google Scholar, 8Crow D.S. Beyer E.C. Paul D.L. Kobe S.S. Lau A.F. Mol. Cell. Biol. 1990; 10: 1754-1763Crossref PubMed Scopus (304) Google Scholar, 9Filson A.J. Azarnia R. Beyer E.C. Loewenstein W.R. Brugge J.S. Cell Growth Differ. 1990; 1: 661-668PubMed Google Scholar, 10Hotz-Wagenblatt A. Shalloway D. Crit. Rev. Oncogenesis. 1993; 4: 541-558PubMed Google Scholar, 11Kanemitsu M.Y. Loo L.W. Simon S. Lau A.F. Eckhart W. J. Biol. Chem. 1997; 272: 22824-22831Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar, 12Swenson K.I. Piwnica-Worms H. McNamee H. Paul D.L. Cell Regul. 1990; 1: 989-1002Crossref PubMed Scopus (226) Google Scholar), while endogenous c-Src has been implicated in the transient inhibition of Cx43-based GJC in normal cells (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). We set out to examine whether c-Src can phosphorylate Cx43 on its COOH-terminal tail in vitro. To this end, we used the Cx43 tail (residues 227–382; Fig.1, upper panel) fused to GST (GST-Cx43CT) and three distinct versions of c-Src: (i) wild-type (wt) c-Src; active c-Src in which the interaction between and the is disrupted and kinase-dead c-Src Src proteins were from transfected COS-7 cells and with [γ-32P]ATP was added for in vitro kinase shown in the protein is phosphorylated by c-SrcK+ is to the in vitro of but not by kinase-dead and by c-Src. the COOH-terminal tail of Cx43 can as a for active c-Src. we to intact vitro phosphorylation of the COOH-terminal of Cx43 tail by c-Src. versions of c-Src c-Src, and were expressed in COS-7 cells. Src proteins were probed with antibody and used for in vitro kinase assays as described The Cx43 COOH-terminal tail acids fused to GST was used as a (GST-Cx43CT) (12Swenson K.I. Piwnica-Worms H. McNamee H. Paul D.L. Cell Regul. 1990; 1: 989-1002Crossref PubMed Scopus (226) Google Scholar) reported that residue Tyr265 in the Cx43 tail is for v-Src-induced tyrosine phosphorylation of Cx43 and inhibition of GJC in Xenopus experiments in cells have that oncogenic v-Src can phosphorylate Cx43 on residue Tyr265 (11Kanemitsu M.Y. Loo L.W. Simon S. Lau A.F. Eckhart W. J. Biol. Chem. 1997; 272: 22824-22831Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar). However, since v-Src and c-Src show association to J.A. 1996; PubMed Scopus Google Scholar, Brugge J.S. Annu. Rev. Cell Biol. 1997; PubMed Scopus Google Scholar), it remains whether c-Src may act similarly to v-Src in Cx43. To examine the of Cx43 residue Tyr265 in the action of c-Src, we mutant versions of Cx43 in which tyrosine and were by (Cx43-Y265F and upper COS-7 cells were transfected with Myc-tagged Cx43 and with or the versions of c-Src. of that the three distinct Cx43 proteins are expressed to tyrosine phosphorylation of of the Cx43 proteins is detected in in cells kinase-dead c-Src c-Src or c-SrcK+ is is detected in Cx43 and but not in the Cx43-Y265F mutant We analyzed Cx43 immunoprecipitates for the of shown in Cx43 and mutant Cx43Y267F are tyrosine-phosphorylated in cells, whereas Cx43Y265F at is these results we conclude that active c-Src phosphorylates Cx43 on residue Tyr265 and that residue is not a Src phosphorylation We at in a was still in the Cx43-Y265F mutant may endogenous Cx43 that is with transfected Myc-tagged Cx43. or possibility is that c-Src may phosphorylate Cx43 on tyrosine residue with The possibility was not investigated in We examined whether c-Src can stably interact with Cx43 in intact cells. COS-7 cells were transfected with Myc-tagged versions of Cx43 and with the c-Src We for the of Cx43 in Src In both Cx43 and the mutant are whereas the Cx43-Y265F mutant is not upper that a association is detected between Cx43 and c-Src and that Cx43 fails to interact with kinase-dead c-Src results the of Cx43 residue Tyr265, and support a model in which phosphorylation of is for stable interaction between Cx43 and active c-Src. Our to an interaction between endogenous c-Src and Cx43 in Rat-1 cells were not is not (i) agonist-induced c-Src activation and disruption of GJC are transient (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar, J. Courtneidge S.A. J. Biol. Chem. 1994; Full Text PDF PubMed Google Scholar, R. J. Biol. Chem. 1996; Full Text Full Text PDF PubMed Scopus Google c-Src and Cx43 are expressed at in normal and the lysis required to Cx43 from junctional is to such are and of transient We examined the of Cx43 residue Tyr265 in closure of gap junctions in fibroblasts. Rat-1 cells are for these Cx43 as the gap junction protein and Cx43-based communication is (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). Rat-1 cells were transiently transfected with encoding c-SrcK+ with versions of Cx43. In all GFP cDNA was to transfected cells. about 40 h after transfection were and cells were with Lucifer Yellow with ethidium bromide as a to cells. of was at after from the transfected and to its the of Cx43-based gap or more adjacent cells communication was this since GJC is to regulation in the transfected in a 5 results of the while of all experiments is in 5 In Rat-1 cells of the cells show to of normal gap junctional communication. active c-SrcK+ is communication is in about of the transfected cells gap junctional communication is of Cx43 does not normal does of which both as Src Strikingly, the Src phosphorylation site Tyr265 in Cx43 is by mutation or by COOH-terminal tail gap junctional communication is and of transfected cells not reveal in of the Cx43 5 we cannot out the possibility that activated Src may Cx43 and/or gap junction results that phosphorylation of Cx43 on residue Tyr265 is a in closure of Cx43-based gap Our support a model in which G protein-coupled receptor such as endothelin, and transiently GJC a pathway that of Cx43 residue Tyr265 as a (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar). In an to this model we stably expressed Cx43 or mutant Cx43-Y265F in communication-defective and HeLa cells, and subsequently examined GJC in to and growth while of Cx43 or Cx43-Y265F GJC to these cells by and electrophysiological in the could not be inhibited by growth or T. F. and W. It thus appears transfected Cx43 does its regulation by extracellular is as an or is or in the Cx43 We have shown that Tyr265 in Cx43 is a site for an interaction between Cx43 and active c-Src and inhibition of GJC. Our results support a model in which activated c-Src phosphorylates the Cx43 tail on residue Tyr265, resulting in a stable interaction between both proteins, most via a Src which to inhibition of GJC. model the of Cx43 residue Tyr265 has been for oncogenic v-Src in Cx43-based gap junctions 10Hotz-Wagenblatt A. Shalloway D. Crit. Rev. Oncogenesis. 1993; 4: 541-558PubMed Google but see L. Kasperek E.M. Nicholson B.J. J. Cell Biol. 1999; 144: 1033-1045Crossref PubMed Scopus (146) Google Scholar for a model in which the has major it be that are important between v-Src and c-Src. is v-Src active it lacks the c-Src and v-Src show association to J.A. 1996; PubMed Scopus Google Scholar, Brugge J.S. Annu. Rev. Cell Biol. 1997; PubMed Scopus Google Scholar). relevance is the that the isolated of v-Src to in Cx43 in whereas the c-Src to Cx43 the (11Kanemitsu M.Y. Loo L.W. Simon S. Lau A.F. Eckhart W. J. Biol. Chem. 1997; 272: 22824-22831Abstract Full Text Full Text PDF PubMed Scopus (168) Google Scholar). it be to a association between endogenous c-Src and Cx43 in Although tyrosine of Cx43 could not be detected in Rat-1 cells receptor (for a recent study tyrosine phosphorylation of Cx43 in T. K. T. 1999; PubMed Scopus Google Scholar). with c-Src and GJC T. K. T. 1999; PubMed Scopus Google Scholar), with a model in which active c-Src with Cx43 and inhibition of GJC. In results for the of c-Src in inhibiting Cx43-based GJC of G protein-coupled (5Postma F.R. Hengeveld T. Alblas J. Giepmans B.N. Zondag G.C. Jalink K. Moolenaar W.H. J. Cell Biol. 1998; 140: 1199-1209Crossref PubMed Scopus (105) Google Scholar), and the of residue Tyr265 as a c-Src target in this a of how Cx43-based GJC is by physiological and/or pathophysiological can be obtained all are In to c-Src, we have the protein as an of the Cx43 COOH-terminal tail B.N. Moolenaar W.H. Curr. Biol. 1998; 8: 931-934Abstract Full Text Full Text PDF PubMed Scopus (471) Google Scholar). for studies is to and how c-Src and may interact to the of the Cx43 and channel studies the G pathway that is for inhibition of Cx43-based GJC in normal cells. We Courtneidge and Zondag for and for with the

References

15